Clearstead Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Buy |
4,280
+288
| +7% | +$93.9K | 0.26% | 59 |
|
|
2025
Q1 | $1.08M | Buy |
3,992
+11
| +0.3% | +$2.97K | 0.24% | 65 |
|
|
2024
Q4 | $937K | Hold |
3,981
| – | – | 0.2% | 67 |
|
|
2024
Q3 | $1.09M | Hold |
3,981
| – | – | 0.26% | 58 |
|
|
2024
Q2 | $967K | Hold |
3,981
| – | – | 0.24% | 58 |
|
|
2024
Q1 | $595K | Hold |
3,981
| – | – | 0.16% | 73 |
|
|
2023
Q4 | $762K | Hold |
3,981
| – | – | 0.21% | 71 |
|
|
2023
Q3 | $705K | Hold |
3,981
| – | – | 0.23% | 68 |
|
|
2023
Q2 | $766K | Hold |
3,981
| – | – | 0.25% | 66 |
|
|
2023
Q1 | $797K | Hold |
3,981
| – | – | 0.25% | 67 |
|
|
2022
Q4 | $946K | Hold |
3,981
| – | – | 0.32% | 56 |
|
|
2022
Q3 | $796K | Buy |
3,981
+3,000
| +306% | +$600K | 0.28% | 60 |
|
|
2022
Q2 | $143K | Hold |
981
| – | – | 0.11% | 88 |
|
|
2022
Q1 | $160K | Sell |
981
-142
| -13% | -$23.2K | 0.1% | 94 |
|
|
2021
Q4 | $190K | Hold |
1,123
| – | – | 0.11% | 91 |
|
|
2021
Q3 | $212K | Buy |
+1,123
| New | +$212K | 0.13% | 87 |
|